EligoChem Company
EligoChem has developed a proprietary and patentable technology that facilitates the design of highly water-soluble drugs that are absorbed well by the human body. One in fifteen known drug compounds have this combination of properties, but they are present in only one in ten thousand compounds in current pharma screening collections. This technology is particularly suited to antibiotic drug discovery.
Total Funding:
4800000
Founded Date:
2012-01-01
Industry:
Quantum Chemistry
Last Funding Date:
2017-08-28
Funding Status:
private
Headquarters:
Sandwich,Kent,United Kingdom,Europe
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
4800000
Last Funding Total Usd:
4800000
Last Funding Total Currency:
USD
Last Funding Total Value:
4800000
Founders:
Andrew McElroy
Phone Number:
+44 (0)1304 806392